The present study evaluated the antidiabetic effect of osajin and pomiferin from the osajin orange in normal and streptozotocin-induced diabetic rats. Pomiferin in the streptozotocin-induced diabetic effects showed significant hypoglycemic activity for 14 days significantly decreased the serum glucose, triglyceride while it increased the serum insulin in diabetic rats but not in normal rats (p < 0.05; at doses of 100 and 300mg/kg for 14 days). Pomiferin showed potential in anti-diabetic effects compared to osajin. It also has no effects on C-peptide (ECLIA). Further structure-activity relationships of aromatic position 3 on ring B from osajin and pomiferin will be reported in due course.
Diabetes is a group of common endocrine disease characterized by hyperglycemia and hyperlipidemia affects 4.4% of the population. The total number of person with diabetes is projected to will rise to 366 million in 2030. Hyperglycemia and hyperlipidemia are involved in the development of microvascular and macrovascular complications of diabetes, which are the major causes of morbidity and mortality of diabetes. The flavonoids are a heterogeneous group of phenolic compounds in the plant kingdom. Many positive as well as negative effects on plant and animal cells of flavonoids have been documented [1] . Many of their effects are significant [2] . In biological activity the flavonoids are used as compounds, which reduce the side effects of antioxidants and on the other hand, they enhance the therapeutic effects. This field is documented very well [3] . Maclura pomifera commonly called osage orange in deciduous tree included in cudrania and other genera of Moraceae and flavonoids have been reported as bioactive compounds of Maclura pomifera [4] . Among them, prenylated isoflavones are known as its main bioactive constituents. Previous publications have reported polyphenolic compounds, such as phenolic glycosides and flavonoids in the MeOH and EtOH extracts of Maclura pomifera [5] . In the context of our natural product chemistry program dealing with the development of new potent anti-diabetic agents, we have examined the isolation of prenylated isoflavones compounds ( Figure 1 ) as leads for novel anti-diabetic agents. Loss of body weight is a characteristic condition in diabetes, owing to defect in glucose metabolism and excessive breakdown of tissue protein [6] . After 14 days of treatment, groups I increased significantly (p <0.05) in weight, when compared to day 0. The STZ induced diabetic rats had significantly lost weight, compared to the control. However, diabetic rats that were subsequently treated with pomiferin (300 mg/kg bw) did not significantly lose weight compared to the control ( Figure 2 ). There was a significant elevation in serum glucose, triglycerides decreased significantly in the diabetic rats. Figure 3 shows the effects of the osajin and pomiferin on serum glucose, insulin, triglycerides and C-petide in diabetic rats. The results showed that serum glucose, and triglycerides of diabetic rats increased while serum insulin decreased, when compared with normal rats. The administration of the osajin and pomiferin at doses of 100 and 300 mg/kg body wt tended to bring serum glucose (p <0.05), insulin (p <0.05), triglycerides (p <0.05) and C-petide (p <0.05) significantly toward normal values, while normal rats did not exhibit any significant alterations in these parameters during the experiment. The pomiferin (300 mg/kg bw) treatment groups were found to be more effective than osajin (300 mg/kg bw). The pomiferin treatments at a dose of 100, 300 mg/kg body wt was found to be more effective than osajin at a dose of 100, 300 mg/kg body wt. The administration of the osajin and pomiferin did not change C-petide levels in normal and diabeic rats. The results indicated that the The pomiferin (300 mg/kg bw) treatment decreased significantly serum glucose and triglycerides while it increased the serum insulin levels in treated diabetic rats compared with the control diabetic rats. The result also showed that the pomiferin (300 mg/kg bw) treatment exhibited a significant decrease in the level of serum in diabetic rats. This may be due to a metabolic disturbance in diabetes reflected in the high activities of xanthine oxidase, lipid peroxidation and increased triglycerides. As a result, pomiferin (2) thus has potential antidiabetic agent from streptozotocin-induced diabetic tested. We have found that pomiferin showed decreasing anti-diabetic potency in vivo. Further study for mode of action of position 3 on ring B is under progress. Taken together, our findings provide important information of the structural features that influence the functional activities of this class of compounds and offer new possibilities for NPC Natural Product Communications 2014 Vol. 9 No. 12
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Moon further explorations to improve potency from damage of STZinduced diabetic rats and that the pomiferin treatment may be of use as an anti-diabetic agent. 
Experimental

Preparation of the prenylated isoflavones, osajin (1) and pomiferin (2):
The fruit of Maclura pomifera were purchased to 20 kg from latierradyeco.com (Ohio. USA) in September 2012, was identified by Prof. Hyung-In Moon. A voucher specimen (No. 2012-0903) has been deposited in the Herbarium of the Dong-A University (Busan, South Korea). Ground fruit of Maclura pomifera, Moraceae, was subjected to consecutive soxhlet extraction using methanol, yielding yellow crystals of osajinpomiferin mixture after cooling. Pomiferin and osajin was then recrystallized from the methanolic solution after concentration under vacuum. Compounds were identified as osajin (1) and pomiferin (2) by comparing its spectral data with those previously reported [7] .
Animals: Adult male rats with body weights of 200-250 g were purchased from the Korea SAMTAKO CO., LTD (Kyunggido, South Korean), housed in specific pathogen-free facilities and provided with autoclaved water and standard food. All experiments conducted on mice were in accordance with the guidelines for the care and use of laboratory animals approved by Dong-A University
Experimental induction of diabetes in rats:
Male adult Wistar rats were injected with streptozotocin(STZ). Streptozotocin was dissolved in saline immediately before use and injected intraperitonially (i.p.) in a single dose (70 mg/ kg, i.p.). Five days after injection, rats with fasting blood glucose higher than 180 mg/dL were used for the experiments. Ten rats were used in each experiment. Each animal was used once only in all the experiments. The food was removed from cages 12 hours before testing.
Osajin (1), pomiferin (2) and drug administration: Osajin (1) and pomiferin (2) was suspended in acacia gum with saline and administered orally through orogastric tubes at the following doses of 100 and 300 mg/kg body wt. Streptozotocin (purity 99%) was purchased from Sigma Co. The volume of the above three doses was kept constant at 1 mL.
Experimental design:
In the experiment, a total of 60 rats (50 diabetic rats, 10normal rats) were used. Diabetes was induced in rats 5 days before starting the treatment. The rats were divided into nine groups. In the experiment, six rats were used in each group. Group I (A): Normal control rats administered 1 mL acacia gum with saline, daily, for 14 days using an intragastric tube. Group II (B): Diabetic control rats administered 1 mL acacia gum with saline, daily, for 14 days using an intragastric tube. Group III (C): Diabetic control rats administered. Osajin (100 mg/kg bw) in 1 mL acacia gum with saline, daily, for 14 days using an intragastric tube. Group IV (D): Diabetic control rats administered. Osajin (300 mg/kg bw) in 1 mL acacia gum with saline, daily, for 14 days using an intragastric tube. Group V (E): Diabetic rats administered. pomiferin (100 mg/kg bw) in 1 mL acacia gum with saline, daily, for 14 days using an intragastric tube.Group VI (F): Diabetic rats administered. pomiferin (300 mg/kg bw) in 1 mL acacia gum with saline, daily, for 14 days using an intragastric tube.
Biochemical assays: Biochemical assays of male adult Wistar rats were determined using a modified method of Eidi [8] . After 14 days of treatments, blood samples were drawn from the heart. Serum glucose, insulin, total cholesterol, triglycerides and C-peptide levels were determined. The serum insulin was estimated by using a radioimmunoassay kit (Diasorin, Italy), total cholesterol and triglyceride by the method of Rifai [9] .
Statistical analysis:
All the data were expressed as mean + SEM. Statistical analysis was carried out using one way ANOVA followed by the Tukey post hoc test. The criterion for statistical significance was p < 0.05.
